Paula Soteropoulos, Chief Executive Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 1,787 shares at $32.17 ($57K) on 2019-04-08, disclosed to the SEC on 2019-04-09.
Open-market sale of $57k AKCA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DNTH | SELL | 2026-03-26 | $2.2M | — | Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |